Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 2,208 | 2,350 | 2,398 | 2,406 | 2,213 |
| Cost of Goods | 1,562 | 1,440 | 1,408 | 1,573 | 1,665 |
| Gross Profit | 645 | 910 | 990 | 833 | 549 |
| Operating Expenses | 4,154 | 3,324 | 3,486 | 3,352 | 3,556 |
| Operating Income | -2,947 | -1,974 | -2,088 | -1,945 | -2,342 |
| Interest Expense | 25 | 22 | 22 | 24 | 25 |
| Other Income | 5 | -3 | 5 | 11 | -3 |
| Pre-tax Income | -2,967 | -1,998 | -2,105 | -1,958 | -2,371 |
| Income Tax | N/A | 3 | 5 | 4 | 2 |
| Net Income Continuous | -2,967 | -2,001 | -2,110 | -1,962 | -2,373 |
| Net Income | $-2,967 | $-2,001 | $-2,110 | $-1,962 | $-2,373 |
| EPS Basic Total Ops | -5.95 | -4.84 | -5.71 | -6.01 | -8.11 |
| EPS Basic Continuous Ops | -6.02 | -4.85 | -5.56 | -5.94 | -7.75 |
| EPS Diluted Total Ops | -5.95 | -4.84 | -5.71 | -6.01 | -8.11 |
| EPS Diluted Continuous Ops | -6.02 | -4.85 | -5.56 | -5.94 | -7.75 |
| EPS Diluted Before Non-Recurring Items | -6.31 | -4.80 | -5.71 | N/A | N/A |
| EBITDA(a) | $-2,793 | $-1,823 | $-1,937 | $-1,796 | $-2,194 |